Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II studyV Adamo, V Lorusso, R Rossello, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2020
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational statusV Gallotta, M Bruno, C Conte, et al.
Gynecologic Oncology|September 18, 2014
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional seriesV Gallotta, F Ghezzi, E Vizza, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 29, 2005
Ultrasound features of different histopathological subtypes of borderline ovarian tumorsE Fruscella, A C Testa, G Ferrandina, et al.
Human Pathology|February 15, 2001
Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomasA Zamparelli, V Masciullo, A Bovicelli, et al.
British Journal of Cancer|May 9, 2007
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) groupS Pignata, G Scambia, C Pisano, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 26, 2011
Ovarian cancer arising in endometrioid cysts: ultrasound findingsA C Testa, D Timmerman, C Van Holsbeke, et al.
Gynecologic Oncology|September 7, 2016
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 studyG Mangili, J Ottolina, G Cormio, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 2, 2014
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2)F Deodato, S Cilla, G Macchia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 2016
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survivalF Fanfani, E Vizza, F Landoni, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II studyV Adamo, V Lorusso, R Rossello, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 23, 2020
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational statusV Gallotta, M Bruno, C Conte, et al.
Gynecologic Oncology|September 18, 2014
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional seriesV Gallotta, F Ghezzi, E Vizza, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 29, 2005
Ultrasound features of different histopathological subtypes of borderline ovarian tumorsE Fruscella, A C Testa, G Ferrandina, et al.
Human Pathology|February 15, 2001
Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomasA Zamparelli, V Masciullo, A Bovicelli, et al.
British Journal of Cancer|May 9, 2007
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) groupS Pignata, G Scambia, C Pisano, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 26, 2011
Ovarian cancer arising in endometrioid cysts: ultrasound findingsA C Testa, D Timmerman, C Van Holsbeke, et al.
Gynecologic Oncology|September 7, 2016
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 studyG Mangili, J Ottolina, G Cormio, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 2, 2014
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2)F Deodato, S Cilla, G Macchia, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 2016
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survivalF Fanfani, E Vizza, F Landoni, et al.
Pageof 18